Evoke Pharma (EVOK) Tops Q1 EPS by 6c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. SPY
9. XYZ
10. FISV

Go back to Evoke Pharma (EVOK) Tops Q1 EPS by 6c

Evoke Pharma Reports First Quarter 2018 Results and Highlights

May 14, 2018 6:30 AM EDT

NDA submission for Gimoti on track for second quarter of 2018Announced discovery of sex-based pharmacokinetic differences for GimotiWaiver of the PDUFA fee for Gimoti NDA granted by FDACash runway extended into April 2019

SOLANA BEACH, Calif., May 14, 2018 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced its financial results for the first quarter ended March 31, 2018.

Dave Gonyer, R.Ph., President and CEO, stated, After successfully completing our comparative exposure... More